Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaDavide Rossi, Marco Ladetto, Lorenzo De Paoli et al.|Leukemia|2009Cited by 98
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Giorgio Inghirami|Oncotarget|2016Cited by 24
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Marco Ladetto, Daniela Capello et al.|Haematologica|2011Cited by 16
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Dario Ferrero et al.|Mechanisms of Ageing and Development|2012Cited by 9
Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.Marco Ladetto, Antonio Palumbo, G Pagliano et al.|Blood|2009Cited by 6